Abstract
The incidence and the prevalence of both cardiovascular and the neoplastic diseases are increasing, as are the therapeutic possibilities and survival. Thus, identifying the best cardiovascular care in a patient ready to start an antineoplastic treatment is becoming a rather common problem.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mitrugno A, Tormoen GW, Kuhn P, McCarty OJ. The prothrombotic activity of cancer cells in the circulation. Blood Rev. 2016;30(1):11–9.
Franco AT, Corken A, Ware J. Platelets at the interface of thrombosis, inflammation, and cancer. Blood. 2015;126:582–8.
Donato J, Campigotto F, Uhlmann EJ, et al. Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study. Blood. 2015;126:494–9.
Easaw JC, Shea-Budgell MA, Wu CM, et al. Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 1: prophylaxis. Curr Oncol. 2015;22:133–43.
Easaw JC, Shea-Budgell MA, Wu CM, et al. Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment. Curr Oncol. 2015;22:144–55.
Khorana AA, Francis CW, Culakova E, et al. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost. 2007;5:632–4.
Oppelt P, Betbadal A, Nayak L. Approach to chemotherapy-associated thrombosis. Vasc Med. 2015;20:153–61.
Mistiaen WP. Cancer in heart disease patients: what are the limitations in the treatment strategy? Future Cardiol. 2013;9:535–47.
Darwazah AK. Surgical management of coronary artery disease associated with malignancy. J Card Surg. 2012;27:581–8.
Sarkiss MG, Yusuf SW, Warneke CL, et al. Impact of aspirin therapy in cancer patients with thrombocytopenia and acute coronary syndromes. Cancer. 2007;109:621–7.
Yusuf SW, Iliescu C, Bathina JD, et al. Antiplatelet therapy and percutaneous coronary intervention in patients with acute coronary syndrome and thrombocytopenia. Tex Heart Inst J. 2010;37:336–40.
Yusuf SW, Daraban N, Abbasi N, et al. Treatment and outcomes of acute coronary syndrome in the cancer population. Clin Cardiol. 2012;35:443–50.
Gross CM, Posch MG, Geier C, et al. Subacute coronary stent thrombosis in cancer patients. J Am Coll Cardiol. 2008;51:1232–3.
Serebruany VL. Aggressive chronic platelet inhibition with prasugrel and increased cancer risks: revising oral antiplatelet regimens? Fundamental and Clinical Pharmacology. 2009;23:411–7.
Kogoj P, Devjak R, Bunc M. Balloon aortic valvuloplasty (BAV) as a bridge to aortic valve replacement in cancer patients who require urgent non-cardiac surgery. Radiol Oncol. 2014;48:62–6.
Bach DS, Cimino N, Deeb GM. Unoperated patients with severe aortic stenosis. J Am Coll Cardiol. 2007;50:2018–9.
Samuels LE, Kaufman MS, Morris RJ, et al. Open heart surgery in patients with chronic lymphocytic leukemia. Leuk Res. 1999;23:71–5.
Yusuf SW, Sarfaraz A, Durand JB, et al. Management and outcomes of severe aortic stenosis in cancer patients. Am Heart J. 2011;161:1125–32.
Guler A, Sahin MA, Cingoz F, et al. Can cardiac surgery be performed safely on patients with haematological malignancies. Cardiovasc J Afr. 2012;23:194–6.
Plumereau F, Pinaud F, Roch A, Baufreton C. Do patients with haematological malignancy who need cardiopulmonary bypass have a short-term higher mortality or a higher chance of disease progression? Interact Cardiovasc Thorac Surg. 2014;19:474–8.
Grant JD, Jensen GL, Tang C, et al. Radiotherapy-induced malfunction in contemporary cardiovascular implantable electronic devices: clinical incidence and predictors. JAMA Oncol. 2015;1:624–32.
Hurkmans CW, Knegjens JL, Oei BS, et al. Dutch Society of Radiotherapy and Oncology (NVRO). Management of radiation oncology patients with a pacemaker or ICD: a new comprehensive practical guideline in The Netherlands. Dutch Society of Radiotherapy and Oncology (NVRO). Radiat Oncol. 2012;7:198.
Gauter-Fleckenstein B, Israel CW, Dorenkamp M, et al. DEGRO/DGK. DEGRO/DGK guideline for radiotherapy in patients with cardiac implantable electronic devices. Strahlenther Onkol. 2015;191:393–404.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Parrini, I., Lestuzzi, C., Iliescu, C., Stanzione, B. (2017). Treatments in Patients with Cancer and Cardiac Diseases. In: Lestuzzi, C., Oliva, S., Ferraù, F. (eds) Manual of Cardio-oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-40236-9_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-40236-9_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-40234-5
Online ISBN: 978-3-319-40236-9
eBook Packages: MedicineMedicine (R0)